Congress introduced legislation last week (March 23, 2021) to lower prescription drug pricing in the US. The measures include tying US drug pricing to other industrialized countries, allowing the US…
New DCAT Study Examines Business Continuity Planning and Risk Management
A newly released DCAT Research & Benchmarking study details how bio/pharmaceutical companies and suppliers are managing business continuity risks resulting from the COVID-19 pandemic and how lessons learned are affecting…
The need to improve supply-chain resilience in wake of disruptions caused by COVID-19 has caused a re-assessment of supply chains and manufacturing networks. What role will digital tools, such as…
EU, Industry Meet for Pharma Supply-Chain Resiliency
The European Commission held a kick-off meeting of the structured dialogue process of the EU’s Pharmaceutical Strategy to address ways to improve the resilience of the EU’s pharmaceutical manufacturing value…
What were some of the key capital investments in manufacturing by the pharmaceutical majors globally in 2020 and 2021 to date? Biomanufacturing for both traditional biologics and new modalities, such…
This week (March 15, 2021), the European Council endorsed a new chemicals strategy to set a long-term vision for the European Union’s (EU) chemicals policy. It is asking the European…
Three COVID-19 vaccines by Pfizer/BioNTech, Moderna, and J&J have been authorized for emergency use in the US. What are the supply targets for 2021 and beyond, and what manufacturing networks…
FDA Addresses Supply Constraints Due to COVID-19; Plus, Packaging Suppliers Expand
The FDA has released a new guidance outlining a risk-based approach to facilitate changes to container-closure-system components, such as glass vials and stoppers, used in COVID-19 vaccines and therapeutics. The…
Which of the new drugs expected to launch in 2021 have blockbuster potential (defined as products with sales of $1 billion or more)? What are revenue projections, and what is…
President Biden Calls for Review of US Drug Supply Chain
Supply-chain vulnerabilities exposed during the COVID-19 pandemic as well as those existing pre-pandemic were behind an executive order signed by President Joe Biden late last month (February 2021) to require…
